• Improve outcomes today and attract more clinical studies

    OneRNA® deploys in your CLIA lab and connects to your EMR — an RNA AI platform you run in-house.

  • Implement an RNA AI-enabling platform to (1) improve oncology outcomes today under an existing payer code, (2) develop RNA AI for truly precision medicine, and (3) discover new targets.

    IMPROVE CARE NOW

    • Match practically all patients — close to 100% diagnostic yield, vs 25–40% for DNA panels
    • Surface matching clinical trials and increase enrollment
    • Runs in your own CLIA lab on proprietary OneRNA® reagents and APIs
    • HIPAA- and CLIA-compliant data exchange with your EMR

    YOUR DATA IS THE UPSIDE

    • New revenue under an RNA-seq-specific payer code
    • Combine your clinical data with OneRNA® data to surface new therapeutic targets
    • Identify non-responders earlier
    • A path to next-generation cures — including bespoke RNA therapeutics

  • How do we compare

    DNA Panels

    500-geneTypical 500 genes binary test

    OneRNA

    20,000 RNA's quantitatively

    40% diagnostic Yield

    Drops to 26% in low mutation tumors

    100% Diagnostic Yield

    Matching all patients to drugs

    Does not detect

    • Over-Expression
    • Fusions
    • Immune therapy targets
    • Tumor Microenvironment

    Detects

    • Over-expression
    • Fusions
    • Immune therapy targets
    • Tumor Microenvironment

  • Subscribe

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More